PLX

#3115
Protalix BioTherapeutics, Inc. Common Stock
2.8300 USD
+1.07%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
2.7890
2.8450
年范围
2.5850
3.1900
日变化
+1.07%
每月变动
-3.08%
6个月变化
-3.08%
年变化
-3.08%
前一天收盘价
2.8000
Open
2.8200
Bid
2.8300
Ask
2.8330
Low
2.7890
High
2.8450
交易量
288
Open full chart

Financials

Overview 声明 Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

新闻